Evidence map›Paper›PMID 37866349›Full record

ArticleInternational archives of allergy and immunology2024

Histological Phenotyping in Eosinophilic Esophagitis: Localized Proximal Disease Is Infrequent but Associated with Less Severe Disease and Better Disease Outcome.

Alexis Heil, Tobias Kuehlewindt, Anne Godat, Hans-Uwe Simon, Dagmar Simon, Philipp Schreiner, Catherine Saner, Stephan R Vavricka, Luc Biedermann, Ekaterina Safroneeva and 5 more

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in International archives of allergy and immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Distribution of Esophageal Eosinophilia as a Predictor of Proton Pump Inhibitor Response in Eosinophilic Esophagitis.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2026
    Article
  3. Review
  4. Article
  5. Eosinophil Distribution in Eosinophilic Esophagitis and its Impact on Disease Activity and Response to Treatment.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2024
    Review
  6. Endoscopic Features of Eosinophilic Gastrointestinal Diseases.Immunology and allergy clinics of North America · 2024
    Review
  7. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 7 institutions in 3 countries.

Alexis HeilDivision of Gastroenterology and Hepatology, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne, Lausanne, Switzerland.
Tobias KuehlewindtDepartment of Gastroenterology and Hepatology, University Hospital Zurich, Zurich, Switzerland.
Anne GodatDepartment of Internal Medicine, GZO Zurich Regional Health Center, Wetzikon, Switzerland.
Hans-Uwe SimonInstitute of Pharmacology, University of Bern, Bern, Switzerland.
Dagmar SimonDepartment of Dermatology, Inselspital, Bern University Hospital, Bern, Switzerland.
Philipp SchreinerDepartment of Gastroenterology and Hepatology, University Hospital Zurich, Zurich, Switzerland.
Catherine SanerDivision of Gastroenterology and Hepatology, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne, Lausanne, Switzerland.
Stephan R VavrickaDepartment of Gastroenterology and Hepatology, University Hospital Zurich, Zurich, Switzerland.
Luc BiedermannDepartment of Gastroenterology and Hepatology, University Hospital Zurich, Zurich, Switzerland.
Ekaterina SafroneevaInstitute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.
Jean-Benoit RosselInstitute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.
Andreas LimacherInstitute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.
Alex StraumannDepartment of Gastroenterology and Hepatology, University Hospital Zurich, Zurich, Switzerland.
Alain M SchoepferDivision of Gastroenterology and Hepatology, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne, Lausanne, Switzerland.
Thomas GreuterDivision of Gastroenterology and Hepatology, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne, Lausanne, Switzerland.
University Hospital of Zurich · CHGZO Spital Wetzikon · CHInstitute of Social and Preventive Medicine · CHUniversity of Bern · CHUniversity of Lausanne · CHUniversity Hospital of Bern · CHUniversity Hospital of Lausanne · CH

Funding

The Impact of COVID-19 on People Living with Rare Diseases and Their FamiliesU2CTR002818 · NCATS · CINCINNATI CHILDRENS HOSP MED CTR · PI Maurizio Macaluso, Michael Wagner · 2019 to 2026
$51.2M
TRAINING (CAREER DEVELOPMENT) COMPONENTU54AI117804 · NIAID · CINCINNATI CHILDRENS HOSP MED CTR · PI Marc E. Rothenberg · 2014 to 2026
$18.5M
NCATS NIH HHS U2C TR002818NIAID NIH HHS U54 AI117804
6 · The paper itself

Abstract

introductionIt is still unknown whether eosinophilic esophagitis (EoE) patients with localized disease are different from those with extended disease.

methodsWe evaluated prospectively included patients in the Swiss EoE cohort. Data on all patients with active disease at baseline, no concomitant gastroesophageal reflux disease, no strictures at baseline, and at least one follow-up visit were analyzed. We compared patients with histologically localized proximal versus distal versus extended (=proximal and distal) disease with regard to patient, disease characteristics, disease presentation, and development of complications.

resultsWe included 124 patients with a median of 2.5 years of follow-up (73.4% males, median age 35.0 years). Ten patients had proximal (8.1%), 46 patients had distal (37.1%), and 68 patients had extended disease (54.8%). Patients with proximal disease were significantly more often females (80%) compared with patients with distal (26.1%, p = 0.002) or extended disease (19.1%, p < 0.001) and reported less severe symptoms (VAS 0 vs. VAS 1, p = 0.001). Endoscopic and histological disease was less pronounced in the proximal esophagus of proximal EoE compared to extended disease (EREFS 1.0 vs. 3.0, p = 0.001; 27.0 eos/hpf vs. 52.5 eos/hpf, p = 0.008). Patients with proximal disease were less likely to undergo dilation compared to patients with distal disease in the follow-up (3.3% vs. 23.3%, p = 0.010). In a multivariate Cox regression model, proximal eosinophilia was less likely to be associated with treatment failure compared to distal eosinophilia.

conclusionAlthough isolated proximal EoE is infrequent, it is associated with less severe disease and better disease outcome. Proximal disease appears to present a unique EoE phenotype.

Indexed as

EnteritisEosinophiliaEosinophilic EsophagitisGastritisAdultEndoscopyFemaleHumansMalePhenotypeDisease activityDisease outcomeEosinophilic esophagitisHistology

Identifiers

PMID37866349
PMCPMC10794962
OpenAlexW4387805253

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.